About Abbott Laboratories
Abbott Laboratories is a health care company that develops and sells medical products worldwide. It works across four segments: medical devices, diagnostics, nutrition, and established pharmaceuticals. Its products include diabetes technology such as the FreeStyle Libre glucose monitor, diagnostic systems and tests, nutrition brands for infants and adults, and branded generic medicines sold mainly outside the United States. Robert Ford serves as chairman and chief executive. Abbott was founded in 1888 and is based in Abbott Park, Illinois, and says it reaches more than 2 billion people worldwide.
Analysts warn data-center firms face risks after Democratic election wins
Democratic wins may lead to stricter oversight, impacting data-center growth and investment strategies in key states like Texas and Georgia.
Greg Abbott approval hits record low 21% amid Texas governor race
Abbott's low approval may signal a potential Democratic shift in Texas, impacting future political dynamics and party strategies statewide.
Texas grid audit stalls $5B-$7B bond sale for Anthropic data center
The Texas grid audit delay highlights growing regulatory scrutiny, potentially reshaping data center investment and policy landscapes.
Greg Abbott’s measures slow Texas data center construction ahead of midterms
Abbott's policies may weaken Texas's competitive edge in the data center market, potentially benefiting other states like Iowa and Georgia.
Gina Hinojosa sues Gov. Abbott for unredacted Musk communications
The lawsuit could sway public opinion and voter sentiment, potentially altering the dynamics of the Texas gubernatorial race.
Talarico leads Paxton in Texas Senate race; Abbott faces tight governor contest
Texas's political landscape is shifting, with increased competitiveness suggesting potential Democratic gains in traditionally Republican areas.
A sourced map of Abbott Laboratories's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Abbott Laboratories and the wider market, hosted by our team, will appear here once episodes are live.